203 related articles for article (PubMed ID: 8876934)
21. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
Detry JM; De Coster PM; Renkin J
Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
[TBL] [Abstract][Full Text] [Related]
22. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation.
Shen WF; Roubin GS; Hirasawa K; Uren RF; Hutton BF; Harris PJ; Fletcher PJ; Kelly DT
J Am Coll Cardiol; 1984 Nov; 4(5):902-7. PubMed ID: 6491083
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
Narahara KA; Shapiro W; Weliky I; Park J
Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
[TBL] [Abstract][Full Text] [Related]
25. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S
Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
Burger W; Neidel S; Kober G
Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
[TBL] [Abstract][Full Text] [Related]
27. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K
Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters.
Silke B; de la Motte S; Spiers P; Herity NA; Drake M; Kelly J; Harrison FJ
Cardiovasc Drugs Ther; 1996 Nov; 10(5):573-80. PubMed ID: 8950073
[TBL] [Abstract][Full Text] [Related]
29. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
Burian M; Piske M; Petkovic D; Mitrovic V
Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
[TBL] [Abstract][Full Text] [Related]
31. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Silke B; Goldhammer E; Sharma SK; Verma SP; Taylor SH
Cardiovasc Drugs Ther; 1990 Apr; 4(2):457-63. PubMed ID: 2149514
[TBL] [Abstract][Full Text] [Related]
32. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
33. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
[TBL] [Abstract][Full Text] [Related]
34. Cardiac function improvement 24 hours after isradipine SRO in patients with chronic stable angina: a double-blind randomized study.
Doat M; Hacot JP; Pavin D; Righetti A
Acta Cardiol; 1996; 51(2):155-64. PubMed ID: 8742912
[TBL] [Abstract][Full Text] [Related]
35. Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats.
Shudo C; Masuda Y; Sugita H; Tanaka S; Tomita K
Gen Pharmacol; 1994 Nov; 25(7):1451-8. PubMed ID: 7896060
[TBL] [Abstract][Full Text] [Related]
36. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.
Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I
J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic dose-response effects of intravenous nisoldipine in coronary artery disease.
Silke B; Frais MA; Muller P; Verma SP; Reynolds G; Taylor SH
Br J Clin Pharmacol; 1985 Dec; 20(6):675-80. PubMed ID: 4091998
[TBL] [Abstract][Full Text] [Related]
38. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease.
Mahler DA; Brent BN; Loke J; Zaret BL; Matthay RA
Am Rev Respir Dis; 1984 Nov; 130(5):722-9. PubMed ID: 6388444
[TBL] [Abstract][Full Text] [Related]
39. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Busse R; Bassenge E
Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
[TBL] [Abstract][Full Text] [Related]
40. Bepridil improves left ventricular performance in patients with angina pectoris.
Zusman RM; Higgins J; Christensen D; Boucher CA
J Cardiovasc Pharmacol; 1993 Sep; 22(3):474-80. PubMed ID: 7504141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
